Unraveling the link between diabetes and COVID-19

Diabetes block letters in crossword and sugar pile on a spoon

One of the risk factors for severe illness from COVID-19 is diabetes. While scientists aren’t sure why diabetes leads to poorer outcomes for COVID-19 patients, early studies indicate that controlling blood sugar may be an important component of treatment. Researchers from across the globe have been reporting that patients who have blood glucose monitoring and control — through insulin infusion and medication (metformin) — have had better outcomes than patients who had uncontrolled hyperglycemia.

To better understand the link between blood glucose and COVID-19, a randomized, controlled clinical study is needed. The University of Minnesota is planning such a clinical trial of the impact of metformin on both prevention and treatment of COVID-19. The Parsemus Foundation has provided seed funding for the project, but additional funders are needed to move this critical study forward. Contact us for more information, and see details on our COVID page.

Linda Brent, PhD

Executive Director, Parsemus Foundation

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to info@parsemus.org.
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today